VF
CYCN icon

Virtu Financial’s Cyclerion Therapeutics CYCN Stock Holding History

Virtu Financial’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,426
Closed -$32K – 1622
2022
Q4 		$32K Buy
+2,426
New +$28.7K ﹤0.01% 1164
2021
Q4 		– Sell
-2,765
Closed -$170K – 1800
2021
Q3 		$170K Sell
2,765
-1,254
-31% -$82.1K 0.02% 965
2021
Q2 		$313K Sell
4,019
-409
-9% -$25.6K 0.03% 699
2021
Q1 		$247K Buy
+4,428
New +$333K 0.02% 933
2020
Q4 		– Sell
-516
Closed -$63K – 1497
2020
Q3 		$63K Buy
+516
New +$59K 0.01% 785

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's CYCN Position: Q1 2023 in Review

Virtu Financial sold out of Cyclerion Therapeutics (CYCN) in Q1 2023, closing a stake of 2,426 shares — an estimated $32K sold.

Virtu Financial first reported a position in CYCN in Q3 2020 and held it in 5 quarters. The position peaked at $313K in Q2 2021. 34 funds tracked by Wall St. Rank hold CYCN as of Q1 2023.

  • Virtu Financial reported no remaining Cyclerion Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 2,426 Cyclerion Therapeutics shares in Q1 2023, an estimated $32K.
  • Virtu Financial first reported a position in Cyclerion Therapeutics in Q3 2020 and held it in 5 quarters.
  • Virtu Financial's Cyclerion Therapeutics position peaked at $313K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.